JANE STREET GROUP, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$23,000
-23.3%
40,445
+72.7%
0.00%
Q1 2022$30,000
-43.4%
23,421
-50.1%
0.00%
Q4 2021$53,000
+47.2%
46,899
+155.9%
0.00%
Q2 2021$36,000
+56.5%
18,328
+45.1%
0.00%
Q1 2021$23,00012,6310.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 51,989$79,543,0000.24%
ASSET MANAGEMENT CORP /IL/ /ADV 133,500$204,0000.10%
Ikarian Capital, LLC 553,273$847,0000.06%
McAdam, LLC 55,978$86,0000.01%
JGP Wealth Management, LLC 15,000$23,0000.01%
Prospera Financial Services Inc 30,300$46,0000.00%
Fort Point Capital Partners LLC 10,000$15,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$85,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 6,501$10,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,800$76,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders